Skip to main content

Absence of Venous Thromboembolism Risk Following Quadrivalent Human Papillomavirus Vaccination, Vaccine Safety Datalink, 2008–2011

Basic Details
Date
Type
Publication
Medical Product
quadrivalent human papillomavirus vaccination (HPV4)
Health Outcome(s)
venous thromboembolism (VTE)
Description

To investigate concerns about a potential association between quadrivalent human papillomavirus vaccination (HPV4) and venous thromboembolism (VTE), a self-controlled case series study was conducted in adolescents and young adults 9–26 years of age in the Vaccine Safety Datalink.

Materials

Vaccine; Volume 34, Issue 1, Pages 167-171, DOI:10.1016/j.vaccine.2015.10.006

Related Assessment(s)
Gardasil Vaccination and Venous Thromboembolism (PRISM)
Author(s)

Allison L. Naleway PhD, Brad Crane, Ning Smith, Matthew F. Daley MD, James Donahue, Julianne Gee Sharon K. Greene PhD, MPH, Theresa Harrington, Lisa A. Jackson MD, MPH, Nicola P. Klein MD, PhD, Hung Fu Tseng, Claudia Vellozzi MD, Eric S. Weintraub

 

Corresponding Author

Allison L. Naleway, Center for Health Research, Kaiser Permanente Northwest, 3800 N. Interstate Ave., Portland, OR 97227; T: 1.503 335 6352; E: allison.naleway@kpchr.org